The Porto European Cancer Research Summit 2021.

Autor: Ringborg U; Cancer Center Karolinska, Karolinska University Hospital, Stockholm, Sweden.; European Academy of Cancer Sciences, Stockholm, Sweden., Berns A; European Academy of Cancer Sciences, Stockholm, Sweden.; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Celis JE; European Academy of Cancer Sciences, Stockholm, Sweden.; Danish Cancer Society Research Centre, Copenhagen, Denmark., Heitor M; Ministry for Science, Technology and Higher Education, Lisbon, Portugal., Tabernero J; Vall d'Hebron University Hospital, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Cancer Core Europe, Amsterdam, The Netherlands., Schüz J; International Agency for Research on Cancer (IARC/WHO), Lyon, France.; Cancer Prevention Europe, Lyon, France., Baumann M; European Academy of Cancer Sciences, Stockholm, Sweden.; German Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Henrique R; Portuguese Oncology Institute of Porto, Porto Comprehensive Cancer Centre (P.CCC), Porto, Portugal., Aapro M; The European Cancer Organisation (ECO), Brussels, Belgium., Basu P; International Agency for Research on Cancer (IARC/WHO), Lyon, France., Beets-Tan R; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Besse B; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France., Cardoso F; Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal., Carneiro F; Faculty of Medicine, University of Porto/Centro Hospitalar Universitário de São João & Ipatimup/i3S, Porto, Portugal., van den Eede G; European Commission, Joint Research Centre (JRC), Geel, Belgium., Eggermont A; European Academy of Cancer Sciences, Stockholm, Sweden.; Princess Máxima Center for Paediatric Oncology, & University Medical Center, Utrecht, The Netherlands., Fröhling S; Cancer Core Europe, Amsterdam, The Netherlands.; German Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Galbraith S; AstraZeneca, Cambridge, UK., Garralda E; Vall d'Hebron University Hospital, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Cancer Core Europe, Amsterdam, The Netherlands., Hanahan D; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland., Hofmarcher T; Lund University and IHE, Lund, Sweden., Jönsson B; Stockholm School of Economics, Stockholm, Sweden., Kallioniemi O; Science for Life Laboratory, Stockholm, Sweden., Kásler M; Ministry of Human Resources, Budapest, Hungary., Kondorosi E; European Commission's Group of Chief Scientific Advisors, Brussels, Belgium., Korbel J; European Molecular Biology Laboratory, Heidelberg, Germany., Lacombe D; EORTC Headquarters, Brussels, Belgium., Carlos Machado J; Institute for Investigation and Innovation in Health, (i3S)/Porto Comprehensive Cancer Centre (P.CCC), Porto, Portugal., Martin-Moreno JM; University of Valencia, Valencia, Spain., Meunier F; Fédération of European Academies of Medicine, Brussels, Belgium., Nagy P; National Institute of Oncology, Budapest, Hungary., Nuciforo P; Vall d'Hebron University Hospital, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain., Oberst S; Cancer Research UK Cambridge Centre, Cambridge, UK.; Organisation of European Cancer Institutes (OECI), Brussels, Belgium., Oliveiera J; Portuguese Oncology Institute of Porto, Porto Comprehensive Cancer Centre (P.CCC), Porto, Portugal., Papatriantafyllou M; Molecular Oncology Editorial Office, Heidelberg, Germany., Ricciardi W; Università Cattolica del Sacro Cuore, Rome, Italy., Roediger A; European Federation of Pharmaceutical Industries and Associations, Brussels, Belgium.; MSD International Business GmbH, Kriens, Switzerland., Ryll B; Melanoma Patient Network Europe, Sweden., Schilsky R; Past President and former Chief Medical Officer of the American Society of Clinical Oncology, Alexandria, VA, USA., Scocca G; European Cancer Patient Coalition, Brussels, Belgium., Seruca R; Institute for Investigation and Innovation in Health, (i3S)/Porto Comprehensive Cancer Centre (P.CCC), Porto, Portugal., Soares M; Portuguese Oncology Institute of Porto, Porto Comprehensive Cancer Centre (P.CCC), Porto, Portugal., Steindorf K; Cancer Prevention Europe, Lyon, France.; German Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Valentini V; Policlinico Gemelli, Rome, Italy., Voest E; The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Cancer Core Europe, Amsterdam, The Netherlands., Weiderpass E; International Agency for Research on Cancer (IARC/WHO), Lyon, France., Wilking N; Karolinska Institutet, Stockholm, Sweden., Wren A; Vall d'Hebron University Hospital, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain., Zitvogel L; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France.

Publikováno v: Molecular oncology [Mol Oncol] 2021 Oct; Vol. 15 (10), pp. 2507-2543. Date of Electronic Publication: 2021 Sep 13.

[Genotypic characterization of a Portuguese population of Marfan syndrome patients].

Autor: Lebreiro A; Serviço de Cardiologia, Hospital de S. João, Porto, Portugal. ana.lebreiro@gmail.com, Martins E, Cruz C, Almeida J, Pimenta S, Bernardes M, Carlos Machado J, Júlia Maciel M, Abreu-Lima C

Publikováno v: Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology [Rev Port Cardiol] 2011 Jul; Vol. 30 (7-8), pp. 649-54.

Dementia with Lewy bodies.

Autor: McKeith I; Institute for Ageing and Health, University of Newcastle, Newcastle upon Tyne, UK. i.g.mckeith@ncl.ac.uk, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, Dickson D, Dubois B, Duda JE, Feldman H, Gauthier S, Halliday G, Lawlor B, Lippa C, Lopez OL, Carlos Machado J, O'Brien J, Playfer J, Reid W

Publikováno v: The Lancet. Neurology [Lancet Neurol] 2004 Jan; Vol. 3 (1), pp. 19-28.

The association between urinary pentosidine levels and cognition in drug-naïve patients with Parkinson's disease.

Autor: Omoto, Shusaku¹ (AUTHOR) s-omoto@jikei.ac.jp, Saito, Mitsuru² (AUTHOR), Murakami, Hidetomo³ (AUTHOR), Shiraishi, Tomotaka³ (AUTHOR), Kitagawa, Tomomichi³ (AUTHOR), Sato, Takeo³ (AUTHOR), Takatsu, Hiroki³ (AUTHOR), komatsu, Teppei³ (AUTHOR), Sakai, Kenichiro³ (AUTHOR), Umehara, Tadashi³ (AUTHOR), Mitsumura, Hidetaka³ (AUTHOR), Iguchi, Yasuyuki³ (AUTHOR)

Publikováno v: Neurological Sciences. Nov2022, Vol. 43 Issue 11, p6323-6328. 6p. 3 Charts, 2 Graphs.

Modeling α-Synucleinopathy in Organotypic Brain Slice Culture with Preformed α-Synuclein Amyloid Fibrils.

Autor: Roux, Amandine¹ (AUTHOR), Wang, Xinhe¹ (AUTHOR), Becker, Katelyn¹ (AUTHOR), Ma, Jiyan¹ (AUTHOR) jiyanma333@gmail.com

Publikováno v: Journal of Parkinson's Disease. 2020, Vol. 10 Issue 4, p1397-1410. 14p.